| 3725 |
2405: Increase, Hepatocellular lipotoxicity |
177: Increase, Mitochondrial dysfunction |
Feb 10, 2026 |
Feb 10, 2026 |
1 AOP
|
| 3736 |
2405: Increase, Hepatocellular lipotoxicity |
1815: Increase, ER stress |
Feb 11, 2026 |
Feb 11, 2026 |
2 AOPs
|
| 3745 |
2405: Increase, Hepatocellular lipotoxicity |
1392: Increase, Oxidative Stress |
Feb 24, 2026 |
Feb 24, 2026 |
2 AOPs
|
| 1994 |
1698: Increase, hypermethylation of the promotor region of GnRHR |
1699: Decease, expression of GnRHR |
Oct 30, 2019 |
Oct 30, 2019 |
1 AOP
|
| 743 |
740: Increase, Hyperplasia (follicular cells) |
741: Increase, Adenomas/carcinomas (follicular cell) |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 783 |
782: Increase, Hyperplasia (forestomach epithelial cells) |
779: Increase, Papillomas/carcinomas (squamous cells) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 771 |
772: Increase, Hyperplasia (glandular epithelial cells of endometrium) |
773: Increase, Endometrial adenocarcinomas |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2972 |
772: Increase, Hyperplasia (glandular epithelial cells of endometrium) |
1896: Genomic instability |
Jul 27, 2023 |
Mar 27, 2025 |
1 AOP
|
| 3608 |
772: Increase, Hyperplasia (glandular epithelial cells of endometrium) |
1070: Increased, adenosquamous carcinomas of endometrium |
Aug 26, 2025 |
Sep 18, 2025 |
1 AOP
|
| 731 |
744: Increase, Hyperplasia (Leydig cells) |
745: Increase, Leydig cell tumors |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 761 |
767: Increase, Hyperplasia (renal tubular cells) |
713: Increase, Adenomas/carcinomas (renal tubular) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 728 |
735: Increase, Hyperplasia (terminal bronchiolar cells) |
736: Increase, Adenomas/carcinomas (bronchioloalveolar) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 786 |
784: Increase, Hyperplasia (tubular epithelial cells) |
713: Increase, Adenomas/carcinomas (renal tubular) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 798 |
796: Increase, Hyperplasia (urothelial) |
797: Increase, Adenomas/carcinomas (urothelial) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2085 |
796: Increase, Hyperplasia (urothelial) |
1763: carcinogenicity |
Apr 21, 2020 |
Apr 21, 2020 |
1 AOP
|
| 1581 |
1343: Increase, hypertension |
1226: Respiratory irritability |
Jun 23, 2017 |
Jun 23, 2017 |
None
|
| 742 |
739: Increase, Hypertrophy and proliferation (follicular cell) |
740: Increase, Hyperplasia (follicular cells) |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 2018 |
1707: Increase of IL-23 |
1708: Th17 cell migration and inflammation induction |
Dec 27, 2019 |
Dec 27, 2019 |
1 AOP
|
| 1002 |
990: Increase, Incomplete ecdysis |
350: Increase, Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
4 AOPs
|
| 1190 |
990: Increase, Incomplete ecdysis |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2750 |
990: Increase, Incomplete ecdysis |
2056: Increase, delay in oviposition |
Aug 28, 2022 |
Aug 28, 2022 |
1 AOP
|
| 2751 |
990: Increase, Incomplete ecdysis |
2057: Decrease, hatching of egg |
Aug 28, 2022 |
Aug 28, 2022 |
1 AOP
|
| 2759 |
990: Increase, Incomplete ecdysis |
2050: Increase, developmental abnormalities |
Aug 28, 2022 |
Aug 28, 2022 |
1 AOP
|
| 781 |
149: Increase, Inflammation |
781: Increase, Regenerative cell proliferation (forestomach epithelial cells) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 929 |
149: Increase, Inflammation |
357: Cholestasis, Pathology |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|